William L. Macias has sold IMVT and made no open-market buys since Jan 2022

Chief Medical Officer at Immunovant, Inc.

SEC CIK 0001864280 · Filings on SEC.gov ↗

$0Bought

$2.1MSold

NoneLast buy

Every filing

11 filings since Jan 2022, newest first

IMVTSell

Immunovant, Inc.

Chief Medical Officer

$85K−1.0%Nov 22

IMVTSell

Immunovant, Inc.

Chief Medical Officer

$92K−1.0%Oct 18

IMVTSell

Immunovant, Inc.

Chief Medical Officer

$96K−1.0%Aug 23

IMVTSell

Immunovant, Inc.

Chief Medical Officer

$90K−1.0%Jul 19

IMVTSell

Immunovant, Inc.

Chief Medical Officer

$96K−1.0%May 24

IMVTSell

Immunovant, Inc.

Chief Medical Officer

$241K−2.0%Apr 19

IMVTSell

Immunovant, Inc.

Chief Medical Officer

$80K−1.0%Feb 23

IMVTSell

Immunovant, Inc.

Chief Medical Officer

$107K−1.0%Nov 24

IMVTSell

Immunovant, Inc.

Chief Medical Officer

$250K−4.0%Aug 25

IMVTSell

Immunovant, Inc.

Chief Medical Officer

$746K−14.0%Jan 13

IMVTSell

Immunovant, Inc.

Chief Medical Officer

$222K−12.0%Jan 7

Filings come from SEC EDGAR. Not investment advice.